Lone Star Funds, Altaris LLC, and One Rock Capital Partners have emerged as leading contenders in the second round of bidding for Lonza Group AG’s capsules and health ingredients unit, according to a report by Bloomberg citing sources familiar with the matter. 20.11.2025


















